{"id":618,"date":"2022-02-07T14:30:00","date_gmt":"2022-02-07T13:30:00","guid":{"rendered":"https:\/\/temporary.nolato.com\/mfn_news\/year-end-report-2021-strong-growth-in-sales-and-profit\/"},"modified":"2022-02-07T14:30:00","modified_gmt":"2022-02-07T13:30:00","slug":"year-end-report-2021-strong-growth-in-sales-and-profit","status":"publish","type":"mfn_news","link":"https:\/\/temporary.nolato.com\/sv\/mfn_news\/year-end-report-2021-strong-growth-in-sales-and-profit\/","title":{"rendered":"Year-end report 2021: Strong growth in sales and profit"},"content":{"rendered":"<div class=\"mfn-body\">\n<p><strong>Fourth quarter 2021:<\/strong><\/p>\n<ul>\n<li>Sales increased to SEK 3,146 million (2,487)<\/li>\n<li>Operating profit (EBITA) rose to SEK 336 million (283)<\/li>\n<li>EBITA margin of 10.7% (11.4)<\/li>\n<li>Profit after tax was SEK\u00a0271 million (211), excluding non-recurring items<\/li>\n<li>Diluted earnings per share increased to SEK 1.01 (0.79), excl. non-recurring items<\/li>\n<li>Cash flow after investments amounted to SEK \u221287 million (211)<\/li>\n<li>The Board proposes a dividend of SEK 1.90 (1.60) per share<\/li>\n<\/ul>\n<p>\u201cThe Group\u2019s sales increased in the fourth quarter by a considerable 28%, adjusted for currency,\u201d said Nolato President and CEO Christer Wahlquist. \u201cThe increase was due to strong growth in Medical Solutions and Integrated Solutions.\u201d<\/p>\n<p>\u201cBoth the quarter and the full financial year saw constantly fluctuating business conditions. We have focused on meeting customer needs, managing the effects of the pandemic and ensuring the safety of our employees and partners\u201d.<\/p>\n<p>\u201cThese have been key priorities for us, but they have resulted in higher costs and relatively lower production efficiency,\u201d added Christer Wahlquist.<\/p>\n<p>Medical Solutions sales for the fourth quarter totaled SEK 1,063 million (951), corresponding to organic growth of 11%. Operating profit (EBITA) was SEK\u00a0112\u00a0million (112), with an EBITA margin of 10.5% (11.8).<\/p>\n<p>\u201cMost areas have seen good demand, although the pandemic has resulted in operations being postponed and consequent lower deliveries of surgical products,\u201d said Christer Wahlquist. \u201cThe margin has been negatively affected by the ramp-up of a new large project, temporarily resulting in higher costs in the second half of the year, and by a shortage of materials and labor.\u201d<\/p>\n<p>Integrated Solutions sales for the fourth quarter totaled SEK 1,476 million (907), corresponding to organic growth of a remarkable 67%. Operating profit (EBITA) was a strong SEK\u00a0192\u00a0million (111), with an EBITA margin of 13.0% (12.2).<\/p>\n<p>\u201cThe continued robust growth in volumes is due to high demand for Vaporiser Heating Products (VHP), as well as excellent performance in EMC,\u201d explained Christer Wahlquist. \u201cWe believe that this business area\u2019s sales for the first quarter of 2022 will be in line with the fourth quarter of 2021.\u201d<\/p>\n<p>Industrial Solutions sales for the fourth quarter totaled SEK 609 million (629), corresponding to negative organic growth of 3%. Operating profit (EBITA) was SEK\u00a038\u00a0million (62), with an EBITA margin of 6.2% (9.9).<\/p>\n<p>\u201cThe decrease was due to supply chain disruptions, particularly in the automotive segment,\u201d said Christer Wahlquist. \u201cThe margin was adversely affected by lower volumes and low production efficiency.\u201d<\/p>\n<p><strong>Full year 2021<\/strong><\/p>\n<ul>\n<li>Sales increased to SEK 11,610 million (9,359), which, adjusted for currency and acquisitions, is a strong increase of 18%<\/li>\n<li>Operating profit (EBITA) rose to SEK 1,369 million (1,066)<\/li>\n<li>Diluted earnings per share were SEK 3.70 (3.12), excl. non-recurring items<\/li>\n<li>Cash flow after investments was SEK 446 million (SEK 905 million excl. acquisitions)<\/li>\n<li>The equity\/assets ratio was 47% (44) and net financial liabilities were SEK 51 million (298)<\/li>\n<\/ul>\n<p><strong>Dividend<\/strong><\/p>\n<p>At the Annual General Meeting, the Board of Directors and the President and CEO will propose a dividend of SEK\u00a01.90 per share (1.60), which corresponds to SEK 512 million (428). The pay-out ratio is 51% (53), excluding non-recurring items. The dividend yield was 1.8% on the share price as of December 31, 2021.<\/p>\n<p><strong>Annual General Meeting<\/strong><\/p>\n<p>The Annual General Meeting will be held on May 3, 2022. The Nomination Committee has nominated Carina van den Berg for election to the Board and proposes the re-election of the other Board members and the Chairman of the Board.<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-contacts\">\n<p><strong class=\"mfn-heading-1\">Contact<\/strong><\/p>\n<hr \/>\n<p>For further information, please contact:<br \/>Christer Wahlquist, President and CEO, +46 (0)705 804848<br \/>Per-Ola Holmstr\u00f6m, CFO, +46 (0)705 763340, <a target=\"_blank\" href=\"mailto:per-ola.holmstrom@nolato.com\" rel=\"nofollow noopener\">per-ola.holmstrom@nolato.com<\/a><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about\">\n<p><strong class=\"mfn-heading-1\">About Us<\/strong><\/p>\n<hr \/>\n<p><em>Nolato is a Swedish group with operations in Europe, Asia, and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, consumer electronics, telecom, automotive, hygiene and other selected industrial sectors. Nolato\u2019s shares are listed on Nasdaq Stockholm in the Large Cap segment, where they are included in the Industrials sector. \u00a0<\/em><em><a href=\"https:\/\/www.nolato.com\/ir\" target=\"_blank\" rel=\"nofollow noopener\">www.nolato.com\/IR<\/a><\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-regulatory mfn-regulatory-mar\">\n<p><em>This information is information that Nolato is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2022-02-07 14:30 CET.<\/em><\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Attachments<\/strong><\/p>\n<hr \/>\n<p><a target=\"_blank\" class=\"mfn-primary\" href=\"https:\/\/storage.mfn.se\/49472c14-fc97-4c74-9e98-c2648cb9b729\/nolato-q4-2021-year-end-report.pdf\" rel=\"nofollow noopener\">Nolato Q4 2021 Year End Report<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Fourth quarter 2021: Sales increased to SEK 3,146 million (2,487) Operating profit (EBITA) rose to SEK 336 million (283) EBITA margin of 10.7% (11.4) Profit after tax was SEK\u00a0271 million (211), excluding non-recurring items Diluted earnings per share increased to SEK 1.01 (0.79), excl. non-recurring items Cash flow after investments amounted to SEK \u221287 million&hellip; <a class=\"more-link\" href=\"https:\/\/temporary.nolato.com\/sv\/mfn_news\/year-end-report-2021-strong-growth-in-sales-and-profit\/\">Continue reading <span class=\"screen-reader-text\">Year-end report 2021: Strong growth in sales and profit<\/span><\/a><\/p>\n","protected":false},"template":"","class_list":["post-618","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-lang-en","mfn-news-tag-mfn-report-interim","mfn-news-tag-mfn-type-ir","mfn-news-tag-mfn-regulatory-mar","mfn-news-tag-mfn","mfn-news-tag-mfn-regulatory","mfn-news-tag-mfn-report","mfn-news-tag-mfn-report-interim-q4","entry"],"translation":{"provider":"WPGlobus","version":"3.0.0","language":"sv","enabled_languages":["en","es","de","fr","ru","sv"],"languages":{"en":{"title":true,"content":true,"excerpt":false},"es":{"title":false,"content":false,"excerpt":false},"de":{"title":false,"content":false,"excerpt":false},"fr":{"title":false,"content":false,"excerpt":false},"ru":{"title":false,"content":false,"excerpt":false},"sv":{"title":false,"content":false,"excerpt":false}}},"_links":{"self":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/mfn_news\/618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/temporary.nolato.com\/sv\/wp-json\/wp\/v2\/media?parent=618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}